COMMUNIQUÉS West-GlobeNewswire

Empower: Discover the Future of Healthcare at Inovalon’s Annual Data-Driven Summit
15/08/2024
Hear from Former CDC Director and Visionary Executives from AWS, Oracle Cloud Infrastructure, Snowflake, and Many Other Organizations on the Forefront of Data-Driven Healthcare BOWIE, Md., Aug. 15, 2024 (GLOBE NEWSWIRE [...]
Noah Medical Shares Diagnostic Confidence of its Galaxy Users at AABIP 2024
15/08/2024
Next-generation robotics company to share field results, deliver interactive simulations and host multiple events for its Galaxy System at leading bronchology and pulmonology gathering SAN CARLOS, Calif., Aug. 15, 2024 [...]
Oculis Appoints Sharon Klier, M.D., M.S., M.P.H. as Chief Development Officer
15/08/2024
Dr. Klier brings significant experience in ophthalmology and drug development with a proven track record in U.S. FDA approvals, which will be instrumental as the company advances its late-stage pipeline Appointment [...]
Lifeward Reports Second Quarter 2024 Financial Results
15/08/2024
Record ReWalk revenue with 20 systems placed Q2’24 revenue of $6.7M up over 400% compared to $1.3M in Q2’23 Medicare claims for submissions from prior quarters beginning to be paid MARLBOROUGH, Mass. and YOKNEAM ILLIT, [...]
Oculis Appoints Sharon Klier, M.D., M.S., M.P.H. as Chief Development Officer
15/08/2024
ZUG, Switzerland, Aug. 15, 2024 (GLOBE NEWSWIRE) -- Oculis Holding AG (Nasdaq: OCS) (“Oculis”), a global biopharmaceutical company purposefully driven to save sight and improve eye care, today announced the appointment [...]
Genetic Technologies Announces Global Launch of geneType™ on Wholly Owned EasyDNA platform
15/08/2024
CHARLOTTE, N.C., Aug. 15, 2024 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”, “GENE”), a global leader in genomics-based tests in health, wellness and serious disease and the parent [...]
SciSparc Updates Regarding the Status of the AutoMax Merger
14/08/2024
SciSparc provides investors with an update regarding the status of the merger agreement with AutoMax, including the court’s approval of AutoMax’s petition to convene special class meetings of its shareholders to approve [...]
Yield10 Bioscience Announces Second Quarter 2024 Financial Results
14/08/2024
WOBURN, Mass., Aug. 14, 2024 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq:YTEN) ("Yield10" or the "Company"), an agricultural bioscience company, today reported financial results for the second quarter ended [...]
HCW Biologics Reports Second Quarter 2024 Financial Results and Business Highlights
14/08/2024
MIRAMAR, Fla., Aug. 14, 2024 (GLOBE NEWSWIRE) -- HCW Biologics Inc. (the “Company” or “HCW Biologics”) (NASDAQ: HCWB), a clinical-stage biopharmaceutical company focused on discovering and developing novel [...]
Marker Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Updates
14/08/2024
Preliminary safety and efficacy with sustained objective responses observed in patients with lymphoma treated with MT-601 in Phase 1 APOLLO study MT-601 was well tolerated with no observation of cytokine release [...]
Biofrontera Inc. Reports Second Quarter 2024 Financial Results and Provides a Business Update
14/08/2024
Woburn, MA, Aug. 14, 2024 (GLOBE NEWSWIRE) -- Biofrontera Inc. (NASDAQ:BFRI) (the "Company"), a biopharmaceutical company specializing in the commercialization of dermatologic products, today reported financial results [...]
Traws Pharma to Host Corporate Update Call on August 15, 2024, at 8:00 AM ET
14/08/2024
NEWTOWN, Pa., Aug. 14, 2024 (GLOBE NEWSWIRE) -- Traws Pharma, Inc. (“Traws” or “Traws Pharma”), a clinical stage biopharmaceutical company developing oral small molecules for respiratory viral diseases and cancer, today [...]
Inhibikase Therapeutics Reports Second Quarter Financial Results and Highlights Recent Period Activity
14/08/2024
Company to host conference call on August 15, 2024 at 8:00 a.m. ET BOSTON and ATLANTA, Aug. 14, 2024 (GLOBE NEWSWIRE) -- Inhibikase Therapeutics, Inc. (Nasdaq: IKT) (Inhibikase or Company), a clinical-stage [...]
PetVivo Reports Reports Fiscal Q1 2025 Results
14/08/2024
Company Reieterates Gudience of 50% to 100% Revenue Growth in Fiscal 2025 MINNEAPOLIS, MN, US, Aug. 14, 2024 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (OTCQB: PETV, PETVW), a leading biomedical company delivering [...]
NEXGEL Reports Record Second Quarter 2024 Revenue of $1.44 Million
14/08/2024
LANGHORNE, Pa., Aug. 14, 2024 (GLOBE NEWSWIRE) -- NEXGEL, Inc. (“NEXGEL” or the “Company”) (NASDAQ: “NXGL”), a leading provider of ultra-gentle, high-water-content hydrogel products for healthcare and consumer [...]
Molecular Templates, Inc. Reports Second Quarter 2024 Financial Results and Corporate Update
14/08/2024
Monotherapy activity of long duration in patients who have progressed on checkpoint therapy via a novel immuno-oncology mechanism of action with PD-L1 ETB (MT-6402) program Early indication of monotherapy activity in [...]
Plus Therapeutics Reports Second Quarter 2024 Financial Results and Recent Business Highlights
14/08/2024
Presented Positive Interim ReSPECT-LM Phase 1 Data for Rhenium ( 186 Re) Obisbemeda for Leptomeningeal Metastases Presented Positive Topline Clinical Trial Results for CNSide diagnostic in the FORESEE trial Management [...]
Shuttle Pharma Ready to Enroll Patients in Phase 2 Clinical Trial of Ropidoxuridine for Treatment of Patients with Glioblastoma
14/08/2024
GAITHERSBURG, Md., Aug. 14, 2024 (GLOBE NEWSWIRE) -- Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH) (“Shuttle Pharma”), a discovery and development stage specialty pharmaceutical company focused on improving [...]
Genelux Corporation Reports Second Quarter 2024 Financial Results and Provides General Business Updates
14/08/2024
WESTLAKE VILLAGE, Calif., Aug. 14, 2024 (GLOBE NEWSWIRE) -- Genelux Corporation (NASDAQ: GNLX), a late clinical-stage immuno-oncology company, today announced financial results for the second quarter of 2024 and [...]

Pages